The popular bed manager had often discussed her weight loss attempts with close friends, but the emergence of new ... s ...

The ‘Ozempic drug,’ semaglutide, has been found to reduce moderately severe pain caused by knee osteoarthritis and improve ...

Novo Nordisk (NVO) and Eli Lilly (LLY) manufacture the top three weight loss drugs on the market, but heightened demand is ...

As the battle against obesity and diabetes heats up, two new superstars are entering the ring in Spain - Mounjaro (also known ...

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

Low-income patients' access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found.

Ionis Pharmaceuticals announced the acceptance of a New Drug Application for donidalorsen for prophylactic ... Viking Therapeutics reported updated, early-stage study results on its oral obesity drug ...

Obesity caused by a lifestyle of moving less and eating more is a prime factor contributing to Type 2 diabetes. Is the answer new weight loss drugs?

While the drugs were developed to treat Type 2 diabetes, they have gained infamy for their dramatic weight loss effects (in the States, the FDA has approved them to help tackle obesity). A clinical ...

Danish biotechnology company Zealand Pharma said on Thursday it expected to initiate a phase 2b trial with its obesity ...

Current health news highlights the expected high demand for Novo Nordisk's obesity drug in India, the need for personalized approaches in knee replacement surgeries, Gilead's notable financial ...